TIKOMED AB
556622-8960ActiveDeveloping novel drug candidates for neurodegenerative diseases via partnerships.
Overview
- 1–4
- Employees
- 10–20M SEK
- Revenue
- 2002
- Founded
Key Decision Makers
Lars Bruce
Founder and Lead of ILB Program
Göran Groth
Chairman of the Board
Christian Treschow
Chairman
Björn Pilström
Chief Executive Officer and Chief Medical Officer
+9 more contacts in Funnelfeedr
Description
TikoMed AB is a privately owned Swedish company established in 2002, focused on groundbreaking scientific innovation in drug development. The core of their work revolves around developing ILB®, a novel molecule demonstrating unique properties in stimulating the body’s natural repair mechanisms. This...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE556622896001
Decision Makers
13 contacts in FunnelfeedrLars Bruce
Founder and Lead of ILB Program
Göran Groth
Chairman of the Board
Christian Treschow
Chairman
Björn Pilström
Chief Executive Officer and Chief Medical Officer
Annika Kollén
Board Member
Tobhias Brandell
Board Member
Henrik Otendal
Chief Financial Officer and Human Resource Manager
Antonio Bermejo Gomez
Head of CMC
Anders Svensson
Board Member
Erika Egrelius
Head of Quality Assurance
Anita Westin Tocaj
Head of Regulatory Affairs
Staffan Dahlgren
Head of Drug Safety
Johan Olsson
Head of Accounting
Similar Companies
20 similar companies in FunnelfeedrLobSor Pharmaceuticals Aktiebolag
1–4 employeesDeveloping innovative therapy systems for advanced Parkinson's disease treatment.
Integrative Research Laboratories Sweden AB
20–49 employeesDeveloping novel CNS drugs for Parkinson's disease using proprietary technology.
Grespo AB
0 employeesYoung biomedical company developing CNS treatments based on 2-oxoglutarate research.
Lipigon Pharmaceuticals AB
5–9 employeesClinical-stage company developing novel drugs for lipid disorders.
AQILION AB
5–9 employeesDeveloping innovative treatments for chronic inflammatory diseases via early-stage partnering.
Browse More
TIKOMED AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo